{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Neurotransmitter disorders",
      "relation": "indication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "安全性相关性",
            "expectation": "确认 L-DOPA 的安全性在神经递质障碍中的合理性",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "对去甲肾上腺素通路的影响",
            "expectation": "评估 Ritalin 对神经递质障碍患者的长期安全性",
            "assignee": "Skeptic"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_l_dopa",
          "type": "Drug",
          "label": "L-DOPA",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ritalin",
          "type": "Drug",
          "label": "Ritalin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adderall",
          "type": "Drug",
          "label": "Adderall",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_bupropion",
          "type": "Drug",
          "label": "Bupropion",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sertraline",
          "type": "Drug",
          "label": "Sertraline",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_fluoxetine",
          "type": "Drug",
          "label": "Fluoxetine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_venlafaxine",
          "type": "Drug",
          "label": "Venlafaxine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_duloxetine",
          "type": "Drug",
          "label": "Duloxetine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_clonidine",
          "type": "Drug",
          "label": "Clonidine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_trazodone",
          "type": "Drug",
          "label": "Trazodone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methylphenidate",
          "type": "Drug",
          "label": "Methylphenidate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_gabapentin",
          "type": "Drug",
          "label": "Gabapentin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_dopamine_receptor",
          "type": "Target",
          "label": "Dopamine Receptor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_norepinephrine_receptor",
          "type": "Target",
          "label": "Norepinephrine Receptor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_dopaminergic",
          "type": "Pathway",
          "label": "Dopaminergic Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_noradrenergic",
          "type": "Pathway",
          "label": "Noradrenergic Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_neurotransmitter_disorders",
          "type": "Disease",
          "label": "Neurotransmitter Disorders",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_cognitive_impairment",
          "type": "Phenotype",
          "label": "Cognitive Impairment",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_mood_disorder",
          "type": "Phenotype",
          "label": "Mood Disorder",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "L-DOPA",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Ritalin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Adderall",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Bupropion",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Sertraline",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Fluoxetine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Venlafaxine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Duloxetine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Clonidine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Trazodone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Methylphenidate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Gabapentin",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_l_dopa",
          "target": "target_dopamine_receptor",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "L-DOPA用于多种与多巴胺相关的疾病"
        },
        {
          "source": "drug_ritalin",
          "target": "target_norepinephrine_receptor",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Ritalin对去甲肾上腺素通路有效"
        },
        {
          "source": "drug_adderall",
          "target": "target_dopamine_receptor",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Adderall作用于多巴胺系统"
        },
        {
          "source": "drug_bupropion",
          "target": "target_dopamine_receptor",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Bupropion影响多巴胺和去甲肾上腺素"
        },
        {
          "source": "drug_sertraline",
          "target": "target_norepinephrine_receptor",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Sertraline影响去甲肾上腺素"
        },
        {
          "source": "drug_fluoxetine",
          "target": "target_dopamine_receptor",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Fluoxetine在抑郁症中影响多巴胺"
        },
        {
          "source": "drug_venlafaxine",
          "target": "target_norepinephrine_receptor",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Venlafaxine同样影响去甲肾上腺素"
        },
        {
          "source": "drug_duloxetine",
          "target": "target_norepinephrine_receptor",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Duloxetine影响去甲肾上腺素系统"
        },
        {
          "source": "drug_clonidine",
          "target": "target_norepinephrine_receptor",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Clonidine作用于去甲肾上腺素通路"
        },
        {
          "source": "drug_trazodone",
          "target": "target_dopamine_receptor",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Trazodone影响多巴胺通路"
        },
        {
          "source": "drug_methylphenidate",
          "target": "target_norepinephrine_receptor",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Methylphenidate影响去甲肾上腺素通路"
        },
        {
          "source": "drug_gabapentin",
          "target": "target_norepinephrine_receptor",
          "relation": "acts_on",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "Gabapentin与去甲肾上腺素通路关联"
        },
        {
          "source": "target_dopamine_receptor",
          "target": "pathway_dopaminergic",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "多巴胺受体与多巴胺通路相关"
        },
        {
          "source": "target_norepinephrine_receptor",
          "target": "pathway_noradrenergic",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "去甲肾上腺素受体与去甲肾上腺素通路相关"
        },
        {
          "source": "pathway_dopaminergic",
          "target": "disease_neurotransmitter_disorders",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "多巴胺通路与神经递质障碍相关"
        },
        {
          "source": "pathway_noradrenergic",
          "target": "disease_neurotransmitter_disorders",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "去甲肾上腺素通路与神经递质障碍相关"
        },
        {
          "source": "disease_neurotransmitter_disorders",
          "target": "phenotype_cognitive_impairment",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "神经递质障碍引发认知功能障碍"
        },
        {
          "source": "disease_neurotransmitter_disorders",
          "target": "phenotype_mood_disorder",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "神经递质障碍与情绪障碍相关"
        },
        {
          "source": "drug_l_dopa",
          "target": "H1",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "形成L-DOPA与神经递质障碍的支持链"
        },
        {
          "source": "drug_ritalin",
          "target": "H2",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Ritalin与神经递质障碍相关"
        },
        {
          "source": "drug_adderall",
          "target": "H3",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Adderall在治疗神经递质障碍的效用"
        },
        {
          "source": "drug_bupropion",
          "target": "H4",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Bupropion支持的机制与神经递质障碍相关"
        },
        {
          "source": "drug_sertraline",
          "target": "H5",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Sertraline的机制支持神经递质障碍"
        },
        {
          "source": "drug_fluoxetine",
          "target": "H6",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Fluoxetine在神经递质障碍中的应用"
        },
        {
          "source": "drug_venlafaxine",
          "target": "H7",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Venlafaxine的机制适应神经递质障碍"
        },
        {
          "source": "drug_duloxetine",
          "target": "H8",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Duloxetine支持神经递质障碍治疗"
        },
        {
          "source": "drug_clonidine",
          "target": "H9",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Clonidine可用于神经递质相关障碍"
        },
        {
          "source": "drug_trazodone",
          "target": "H10",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Trazodone适用于情绪及睡眠问题"
        },
        {
          "source": "drug_methylphenidate",
          "target": "H11",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "甲基苯idate适用于ADHD相关症状"
        },
        {
          "source": "drug_gabapentin",
          "target": "H12",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "Gabapentin也与神经递质障碍相关"
        }
      ],
      "round_index": 2
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates_per_hypothesis": []
  }
}